Etanercept: effective in the management of hidradenitis suppurativa

The British Journal of Dermatology
C Cusack, C Buckley

Abstract

Hidradenitis suppurativa (HS) is a chronic suppurative condition which is poorly responsive to treatment and is characterized by significant morbidity. Successful treatment of HS in patients treated with infliximab for concomitant Crohn's disease has been reported. More recent reports of positive responses to infliximab [an antitumour necrosis factor (TNF)-alpha agent] in patients who have HS but not Crohn's disease are encouraging. TNF-alpha is implicated in many inflammatory disorders and we wished to determine the efficacy of subcutaneous etanercept, a competitive inhibitor of TNF-alpha in the control of HS symptoms. We commenced six patients with severe, recalcitrant HS on etanercept (25 mg subcutaneously twice weekly in all cases). All patients had a normal chest X-ray and negative purified protein derivative test prior to treatment and were closely monitored throughout the treatment period for signs of infection. Patients self-assessed their disease activity and completed Dermatology Life Quality Index (DLQI) questionnaires immediately before the introduction of therapy and 24 weeks later in the case of four patients, and 12 weeks later in the case of two others. All patients were asked to estimate the time lapse between ...Continue Reading

Associated Clinical Trials

References

Apr 1, 1992·The British Journal of Dermatology·E T Chow, P S Mortimer
Oct 1, 1991·The British Journal of Dermatology·L S OstlereR C Staughton
May 1, 1994·Clinical and Experimental Dermatology·A Y Finlay, G K Khan
Jan 27, 1999·Journal of Medical Microbiology·I Brook, E H Frazier
Mar 13, 1999·Annals of Internal Medicine·L W MorelandM E Weinblatt
Jul 7, 1999·Dermatology : International Journal for Clinical and Investigative Dermatology·A KönigR Happle
Aug 10, 1999·Clinical Therapeutics·J F Mouser, J S Hyams
May 16, 2000·The British Journal of Dermatology·J M Von Der WerthJ A Raeburn
Nov 4, 2000·Expert Opinion on Investigational Drugs·G Van Assche, P Rutgeerts
Apr 12, 2001·British Journal of Clinical Pharmacology·H E SeymourS H Thomas
Apr 12, 2001·The British Journal of Dermatology·J M von der Werth, G B Jemec
Nov 27, 2001·Inflammatory Bowel Diseases·F MartínezJ Ponce
Mar 21, 2002·The British Journal of Dermatology·L MiseryC Alexandre
Jul 26, 2002·Journal of the American Academy of Dermatology·Jan LapinsLennart Emtestam
Aug 23, 2002·The American Journal of Gastroenterology·Konstantinos H KatsanosEpameinondas V Tsianos
Oct 10, 2002·Clinical and Experimental Dermatology·G B E Jemec
Nov 29, 2002·Journal of Cutaneous Medicine and Surgery·Gregor B E Jemec
Nov 18, 2003·Clinical and Experimental Dermatology·V J SwaleM H A Rustin
Nov 25, 2003·The New England Journal of Medicine·Craig L LeonardiUNKNOWN Etanercept Psoriasis Study Group
Nov 25, 2003·The British Journal of Dermatology·T P SullivanR S Kirsner
Dec 12, 2003·European Journal of Haematology·John KuruvillaSheldon C Naiman

❮ Previous
Next ❯

Citations

Dec 31, 2009·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Paul G Hazen, Brent P Hazen
Nov 19, 2011·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Lixia Z Ellis
Dec 23, 2011·Journal of Clinical Microbiology·Matthias G VossenHeimo Lagler
Oct 14, 2006·Annals of the Rheumatic Diseases·D E FurstM H Weisman
Nov 21, 2007·Annals of the Rheumatic Diseases·D E FurstM E Weinblatt
Aug 18, 2010·International Journal of Medical Sciences·Adnan MenderesMustafa Yilmaz
Nov 27, 2015·Pediatric Dermatology·Fernanda Bellodi-Schmidt, Kara N Shah
Mar 1, 2012·Seminars in Cutaneous Medicine and Surgery·M Shane Chapman
Sep 2, 2010·Annales de dermatologie et de vénéréologie·M-E DeschampsM D'Incan
Mar 17, 2010·Journal of the American Academy of Dermatology·Łukasz MatusiakJacek C Szepietowski
Jul 14, 2010·Annales de dermatologie et de vénéréologie·M DelaplaceE Estève
Mar 19, 2008·Actas dermo-sifiliográficas·J Pedraz, E Daudén
Mar 19, 2009·Journal of the American Academy of Dermatology·Ali AlikhanDaniel B Eisen
Nov 21, 2007·Journal of the American Academy of Dermatology·Bruce E StroberKimberly Siu
Dec 28, 2007·Advances in Dermatology·Robert A LeeJoseph Kist
Dec 15, 2015·Mayo Clinic Proceedings·Carina M WoodruffKieron S Leslie
Jan 24, 2007·Journal of the American Academy of Dermatology·Laurence FardetCeleste Lebbé
Jan 30, 2007·Médecine et maladies infectieuses·R ChraïbiB Hassam
Dec 19, 2006·Seminars in Cutaneous Medicine and Surgery·Mary Jo J KernsMichael P Heffernan
Aug 18, 2009·Journal of the European Academy of Dermatology and Venereology : JEADV·J Revuz
May 15, 2009·The British Journal of Dermatology·K SartoriusJ Lapins
Dec 14, 2007·The British Journal of Dermatology·E J Giamarellos-BourboulisH Giamarellou
Apr 18, 2009·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Viola Harde, Ulrich Mrowietz
Dec 1, 2007·The British Journal of Dermatology·J R Mekkes, J D Bos
Oct 31, 2012·The British Journal of Dermatology·A SavvaE J Giamarellos-Bourboulis
Nov 26, 2010·International Journal of Dermatology·Monika ArenbergerovaPetr Arenberger
Feb 3, 2015·Journal of the European Academy of Dermatology and Venereology : JEADV·C C ZouboulisG B E Jemec
Dec 28, 2006·Journal of the American Academy of Dermatology·Julia E GravesMichael P Heffernan
Dec 10, 2013·Journal of the American Academy of Dermatology·Kieron S LeslieMichael D Rosenblum
Jun 20, 2015·PloS One·Theodora KanniEvangelos J Giamarellos-Bourboulis
Aug 24, 2018·Expert Review of Clinical Pharmacology·Claudio MarascaGabriella Fabbrocini
Sep 9, 2020·Expert Opinion on Drug Metabolism & Toxicology·Elisa MolinelliAnnamaria Offidani
Feb 1, 2019·Immunotherapy·Katarzyna WłodarekJacek C Szepietowski
Jun 14, 2019·Therapeutic Advances in Chronic Disease·Kevin T SavageAlexa B Kimball
May 30, 2019·American Journal of Clinical Dermatology·Kelsey S FloodAlexa B Kimball
Jun 6, 2019·Anais Brasileiros De Dermatologia·Renata Ferreira MagalhãesAndrea Machado Coelho Ramos
May 19, 2011·Annals of Plastic Surgery·Elliott Chen, Harold I Friedman
May 18, 2010·The Clinical Journal of Pain·Howard S SmithJason Teitelbaum
May 1, 2020·Paediatric Drugs·Quoc-Bao D NguyenAdelaide A Hebert
Jul 16, 2020·Expert Opinion on Emerging Drugs·Alecia S FolkesFrancisco A Kerdel
Nov 14, 2020·International Journal of Molecular Sciences·Ester Del DucaSteven Paul Nisticò

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]
Oktay BüyükaşikHayri Erkol
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]
Emily TierneyIltefat H Hamzavi
© 2021 Meta ULC. All rights reserved